PT  - JOURNAL ARTICLE
AU  - Ghias, Nimrah
AU  - Haq, Shan Ul
AU  - Arshad, Huzifa
AU  - Sultan, Haseeb
AU  - Bashir, Farhan
AU  - Ghaznavi, Syed Ameer
AU  - Shabbir, Maria
AU  - Badshah, Yasmin
AU  - Rafiq, Mehak
TI  - Using Machine Learning Algorithms to predict sepsis and its stages in ICU patients
AID  - 10.1101/2022.03.15.22271655
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.15.22271655
4099  - http://medrxiv.org/content/early/2022/03/20/2022.03.15.22271655.short
4100  - http://medrxiv.org/content/early/2022/03/20/2022.03.15.22271655.full
AB  - Sepsis is blood poisoning disease that occurs when body shows dysregulated host response to an infection and cause organ failure or tissue damage which may increase the mortality rate in ICU patients. As it becomes major health problem, the hospital cost for treatment of sepsis is increasing every year. Different methods have been developed to monitor sepsis electronically, but it is necessary to predict sepsis as soon as possible before clinical reports or traditional methods, because delayed in treatment can increase the risk of mortality with every single hour. For the early detection of sepsis, specifically in ICU patients, different machine learning models i.e Linear learner, Multilayer perceptron neural networks, Random Forest, lightgbm and Xgboost has trained on the data set proposed by Physio Net/ Computing in Cardiology Challenge in 2019. This study shows that Machine learning algorithms can accurately predict sepsis at the admission time of patient in ICU by using six vitals signs extracted from patient records over the age of 18 years. After comparative analysis of machine learning models, Xgboost model achieved a highest accuracy of 0.98, precision of 0.97, and recall 0.98 under the precision-recall curve on the publicly available data. Early prediction of sepsis can help clinicians to implement supportive treatments and reduce the mortality rate as well as healthcare expenses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Xpertflow Pvt LtdAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://physionet.org/content/challenge-2019/1.0.0/ https://physionet.org/content/challenge-2019/1.0.0/